DrugPatentWatch Database Preview
Drugs in Development Information for Tirasemtiv
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Tirasemtiv?
Tirasemtiv is an investigational drug.
There have been 7 clinical trials for Tirasemtiv.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2016.
The most common disease conditions in clinical trials are Motor Neuron Disease, Amyotrophic Lateral Sclerosis, and Sclerosis. The leading clinical trial sponsors are Cytokinetics, National Institute of Neurological Disorders and Stroke (NINDS), and [disabled in preview].
There are seven US patents protecting this investigational drug and seventy-five international patents.
Summary for Tirasemtiv
| US Patents | 7 |
| International Patents | 75 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-10-01) |
| Vendors | 41 |
Recent Clinical Trials for Tirasemtiv
| Title | Sponsor | Phase |
|---|---|---|
| A Study for Patients Who Completed VITALITY-ALS (CY 4031) | Cytokinetics | Phase 3 |
| Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year | Cytokinetics | Phase 3 |
| Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) | Cytokinetics | Phase 2 |
Clinical Trial Summary for Tirasemtiv
Top disease conditions for Tirasemtiv
Top clinical trial sponsors for Tirasemtiv
US Patents for Tirasemtiv
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tirasemtiv | Start Trial | Combination ALS therapy | Cytokinetics, Inc. (South San Francisco, CA) | Start Trial |
| Tirasemtiv | Start Trial | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols, compositions thereof, and methods for their use | Cytokinetics, Inc. (South San Francisco, CA) | Start Trial |
| Tirasemtiv | Start Trial | Certain 1H-imidazo[4,5-B]pyrazin-2(3H)-ones and 1H-imidazo[4,5-B]pyrazin-2-ols, compositions thereof, and methods for their use | Cytokinetics, Inc. (South San Francisco, CA) | Start Trial |
| Tirasemtiv | Start Trial | Modulating skeletal muscle | Cytokinetics, Inc. (South San Francisco, CA) | Start Trial |
| Tirasemtiv | Start Trial | Certain chemical entities, compositions and methods | Cytokinetics, Inc. (South San Francisco, CA) | Start Trial |
| Tirasemtiv | Start Trial | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use | Cytokinetics, Incorporated (South San Francisco, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tirasemtiv
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tirasemtiv | Australia | 2012281042 | 2031-07-13 | Start Trial |
| Tirasemtiv | Australia | 2016244263 | 2031-07-13 | Start Trial |
| Tirasemtiv | Brazil | 112014000742 | 2031-07-13 | Start Trial |
| Tirasemtiv | Canada | 2849213 | 2031-07-13 | Start Trial |
| Tirasemtiv | China | 104039148 | 2031-07-13 | Start Trial |
| Tirasemtiv | China | 109316480 | 2031-07-13 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
